Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe - Wikidata - awgldk - TriplyDB

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

http://www.wikidata.org/entity/Q34539349

about

Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach Dissecting the indirect effects caused by vaccines into the basic elements Human papillomavirus and gastrointestinal cancer: A review Women have a preference for their male partner to be HPV vaccinated.Towards the eradication of HPV infection through universal specific vaccination.Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey On the transmission dynamics of Buruli ulcer in Ghana: Insights through a mathematical model.Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework.Future perspectives: United Kingdom National Multidisciplinary Guidelines.Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls.Anal human papillomavirus and HIV: A cross-sectional study among men who have sex with men in Moscow, Russia, 2012-2013 Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study HPV vaccine acceptability among men: a systematic review and meta-analysis.Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France.The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.Penile tumours: a review.Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies.Human papillomavirus (HPV): making the case for 'Immunisation for All'.Provider-reported acceptance and use of the Centers for Disease Control and Prevention messages and materials to support HPV vaccine recommendation for adolescent males.Universal proposal strategies of anti-HPV vaccination for adolescents: comparative analysis between school-based and clinic immunization programs.Using Facebook to Recruit Young Australian Men Into a Cross-Sectional Human Papillomavirus Study.Strengthening the case for gender-neutral and the nonavalent HPV vaccine.

P2860

Q26779543-A0FC869D-DEE7-4782-903E-5962C241F93F Q26799527-5141581E-D8A5-4552-82F2-11D8FC7A957D Q28069930-27B184D5-EBC1-4636-B535-86F4D0ABD91C Q33609959-3806C531-A544-4158-9B10-748F8C69F93A Q34812959-7A9BD965-B18E-4819-AEFB-F9B802D5DB85 Q35596183-CCD7C001-B480-423A-B6CD-27C96607DB6D Q35605731-207F29E7-0AAD-4238-865D-E6B81B20F2B5 Q35685406-012E8D67-A085-407F-ACE0-4216D8C5C074 Q35834588-FBA0D9F6-7587-4889-88AB-7681984CA118 Q35876855-161715DA-8D05-4CD8-B910-8006355E7331 Q36919626-3B648819-0068-4F04-8479-152C69FB8B5D Q36921646-69FB0F26-4948-4E9E-A6ED-AE3F02CEF8A3 Q36927058-E9D2B988-D4F4-4D8B-994B-66E6D7FEA5D2 Q36977595-CCA688CA-DE6A-41EE-88EE-18F3640C0170 Q37267539-BBEB41B8-E930-452A-BDC7-B56BF9F16F92 Q37309897-7F417793-ECE2-4ABB-AE1E-685C5BF8E47C Q37521892-337856C1-3850-4D41-A50E-7971CDFC4493 Q38161874-5BC29306-8A92-46A1-B7CD-33D9362A36CE Q38200655-3A7D2FD0-DDC6-43D3-9AAE-D8493421555E Q38549643-5E9028A6-1A0B-4424-BAB4-97C4F9605C06 Q38919213-1077A9FD-247E-4621-8AB1-3580986BCF61 Q40970390-34E35A59-0F70-492F-8D13-5AE6AA5F70E4 Q44732567-376D25B6-3AF0-4FDA-9F14-9FF04F0C4FC3 Q47120716-BAE85FC4-9E86-45C6-88A0-76215661C8C2 Q47554428-D688B45A-68F3-4D95-BC73-FD3BE41EBEE0

P2860

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

http://www.wikidata.org/entity/Q34539349

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Estimating the clinical benefi ...... HPV-related diseases in Europe

@ast

Estimating the clinical benefi ...... HPV-related diseases in Europe

@en

Estimating the clinical benefi ...... HPV-related diseases in Europe

@nl

type

label

Estimating the clinical benefi ...... HPV-related diseases in Europe

@ast

Estimating the clinical benefi ...... HPV-related diseases in Europe

@en

Estimating the clinical benefi ...... HPV-related diseases in Europe

@nl

prefLabel

Estimating the clinical benefi ...... HPV-related diseases in Europe

@ast

Estimating the clinical benefi ...... HPV-related diseases in Europe

@en

Estimating the clinical benefi ...... HPV-related diseases in Europe

@nl

P1433

Q34539349-E2A1A64A-CFD8-4E90-A1B3-A4980B5F1D1F

P1476

Q34539349-0287F7C8-DBB2-4DAE-997D-ED41DA10876D

P2093

Q34539349-07D0EC25-BE64-445B-AFB6-ACA7F457EADD

Q34539349-19959069-6770-4CE6-B795-85B02351CCFD

Q34539349-54CF2A27-BE94-4CD1-9227-7C825AD9626F

Q34539349-7DA216CA-C6E6-4E0C-8C7F-9966C76C0B1B

Q34539349-92EBBFA1-7B81-4AD5-9A03-B1BCB076C59B

P2860

Q34539349-19B6A900-20F9-4F1A-9985-7E5DD84FEB84

Q34539349-1C9B9478-5FB0-4100-87C4-0BA70D56A811

Q34539349-23CBE964-810E-47AB-978F-45236E664509

Q34539349-25C98258-5B1B-41A1-8693-D2290B3FB9DB

Q34539349-289B36CA-E880-46FE-A44C-C0CEC14A7685

Q34539349-2E0BF5BF-3996-4DB4-AB59-E78E8FE70219

Q34539349-31955194-EF55-4A36-92D8-BFBCF3A08062

Q34539349-3C7CC683-890B-4D82-A2AB-2BBE6F6F8994

Q34539349-3F21EF02-3DF0-4D6F-9C83-9F1CA79CD48F

Q34539349-423C8928-C7BE-4E8D-B96F-EC96226649B8

P2888

Q34539349-CD10DFF0-50A7-4785-BC1D-FCF0783160A4

P304

Q34539349-2D462EEE-B863-444A-AE6F-5B0EF55BD1D1

P31

Q34539349-900D9C6D-9590-485D-AD32-954E4BFAA266

P356

Q34539349-99E788E8-9845-45F0-8328-A8713686C82E

P407

Q34539349-2C648812-FD7D-4FD6-B7C3-54B82291B668

P478

Q34539349-75ED5FEE-8BAD-4862-A04A-5A4E34A82E98

P577

Q34539349-0842F9C0-D868-4826-9086-EDB4E37111CD

P5875

Q34539349-E5F26EBC-B397-46C8-B66C-D73F8347E2E1

P6179

Q34539349-B79CA831-1043-45A3-9E73-0D24E018963D

P698

Q34539349-F8702F3A-2EC3-4035-87E4-97A2138FAF4B

P932

Q34539349-57D96691-0146-44C1-AEA4-133D69542EDB

P356

1471-2407-13-10

P1433

P1476

Estimating the clinical benefi ...... HPV-related diseases in Europe

@en

P2093

Jayne Smith-Palmer

http://www.w3.org/2001/XMLSchema#string

Nathalie Largeron

http://www.w3.org/2001/XMLSchema#string

Rémi Marty

http://www.w3.org/2001/XMLSchema#string

Stéphane Roze

http://www.w3.org/2001/XMLSchema#string

Xavier Bresse

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

Assessing incidence and economic burden of genital warts with data from a US commercially insured population.

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model.

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

P2888

1471-2407-13-10

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-10

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234088040

http://www.w3.org/2001/XMLSchema#string

P6179

1003289390

http://www.w3.org/2001/XMLSchema#string

P698

23298365

http://www.w3.org/2001/XMLSchema#string

P932

3561184

http://www.w3.org/2001/XMLSchema#string